23andMe cuts 40% of its workforce and discontinues therapeutics division
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed drawn-out negotiations with Wojcicki, who has been trying to take the company private. The seven resigning directors said they had yet ...
Back in September, all of 23andMe's independent directors also resigned from its board — a rare move that followed ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
DNA-testing company 23andMe said on Monday that it was firing roughly ... The company announced two weeks ago that it had ...
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
In September, independent directors of the Board of 23andMe sent a letter to Anne Wojcicki, Chief Executive Officer, Co ...
Genetic testing company 23andMe has appointed three new independent directors to its board, including former WeWork CFO Andre ...
Shares were hovering below $1 until 23andMe announced a 1-for-20 reverse stock split in October. In September, all seven of ...
In another blow to the company, seven of 23andMe’s eight-strong board resigned in September. The firm's independent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback